Bio-Rad Labs Tops Q1 EPS by $1.54
- ByInvesting.com-
Bio-Rad Labs (BIO) reported Q1 EPS of $4.94, $1.54 better than the analyst estimate of $3.40. Revenue for the quarter came in at $700 million versus the consensus estimate of...
Bio-Rad Labs (BIO) reported Q1 EPS of $4.94, $1.54 better than the analyst estimate of $3.40. Revenue for the quarter came in at $700 million versus the consensus estimate of...
By Sam BougheddaInvesting.com -- Bio-Rad Laboratories Inc (NYSE:BIO), the life science and clinical diagnostic products firm gave an optimistic forecast at its investor day on...
Investing.com – U.S. stocks were mixed after the close on Tuesday, as gains in the Oil & Gas, Financials and Basic Materials sectors led shares higher while losses in the...
Wall Street expects a year-over-year decline in earnings on higher revenues when Bio-Rad Laboratories (NYSE:BIO) reports results for the quarter ended September 2021. While this...
If you are looking for a sector in the market that has been delivering strong performance this quarter, is not tied to the booms and busts of economic cycles, and has plenty of...
Bio-Rad Laboratories (NYSE:BIO), Inc. BIO scaled a new 52-week high of $783.80 on Aug 16, before closing the session marginally lower at $781.98.The company’s shares have...
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians’ office laboratories, and transfusion laboratories. In addition, the company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Buy | Strong Buy | Strong Buy | Neutral | Neutral |
| Technical Indicators | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Strong Sell |
| Summary | Strong Buy | Strong Buy | Strong Buy | Buy | Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 75.25 | 76.44 | 73.27 | -0.49 | -0.65% | 7.32M | NYSE | |||
| 8.30 | 8.50 | 8.10 | -0.04 | -0.48% | 6.21M | NYSE | |||
| 38.08 | 38.86 | 37.53 | +0.14 | +0.37% | 6.85M | NYSE | |||
| 0.185 | 0.1999 | 0.1824 | -0.0135 | -6.80% | 2.27M | NYSE | |||
| 1.13 | 1.1514 | 1.07 | 0.0000 | 0.00% | 6.29M | NYSE | |||
| 4.44 | 4.47 | 4.44 | 0.000 | 0.00% | 0.00 | NYSE | |||
| 47.20 | 47.88 | 45.96 | +0.87 | +1.88% | 4.11M | NYSE | |||
| 181.89 | 197.55 | 176.72 | -14.18 | -7.23% | 1.90M | NYSE | |||
| 11.74 | 12.16 | 11.54 | -0.40 | -3.29% | 24.56M | NYSE | |||
| 47.74 | 50.20 | 43.49 | +0.03 | +0.06% | 1.14M | NASDAQ | |||
| 23.27 | 25.14 | 22.53 | -0.34 | -1.44% | 15.20M | NYSE | |||
| 1,771.68 | 1,886.53 | 1,703.32 | -117.71 | -6.23% | 443.06K | NYSE | |||
| 36.21 | 36.31 | 35.64 | +0.46 | +1.29% | 4.56M | NYSE | |||
| 187.60 | 199.00 | 183.25 | -13.73 | -6.82% | 4.56M | NYSE | |||
| 52.64 | 55.28 | 49.65 | -1.04 | -1.94% | 5.53M | NASDAQ |